Met Life Investment Management, LLC Apellis Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 6,582 shares of APLS stock, worth $218,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,582
Previous 6,711 1.92%
Holding current value
$218,127
Previous $257,000 26.46%
% of portfolio
0.0%
Previous 0.0%

Shares

58 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$28.84 - $41.15 $3,720 - $5,308
-129 Reduced 1.92%
6,582 $189,000
Q2 2024

Aug 13, 2024
BUY
$38.07 - $59.71 $21,509 - $33,736
565 Added 9.19%
6,711 $257,000
Q1 2024

May 14, 2024
BUY
$55.39 - $72.47 $340,426 - $445,400
6,146 New
6,146 $361,000
Q4 2023

Feb 14, 2024
SELL
$37.14 - $64.82 $37 - $64
-1 Reduced 0.02%
6,127 $366,000
Q3 2023

May 09, 2024
SELL
$23.65 - $89.22 $1.02 Million - $3.83 Million
-42,947 Reduced 87.51%
6,128 $233,000
Q3 2023

Apr 29, 2024
BUY
$23.65 - $89.22 $47 - $178
2 Added 0.03%
6,128 $233,000
Q3 2023

Nov 14, 2023
BUY
$23.65 - $89.22 $47 - $178
2 Added 0.03%
6,128 $233,000
Q2 2023

Apr 29, 2024
BUY
$76.68 - $93.31 $469,741 - $571,617
6,126 New
6,126 $558,000
Q2 2023

Aug 10, 2023
SELL
$76.68 - $93.31 $3.29 Million - $4.01 Million
-42,949 Reduced 87.52%
6,126 $558,000
Q1 2023

May 09, 2024
BUY
$46.59 - $66.96 $2.29 Million - $3.29 Million
49,075 New
49,075 $3.24 Billion
Q1 2023

May 15, 2023
SELL
$46.59 - $66.96 $27,488 - $39,506
-590 Reduced 1.19%
49,075 $3.24 Million
Q4 2022

Jun 14, 2023
BUY
$43.24 - $61.04 $25,511 - $36,013
590 Added 1.2%
49,665 $2.57 Million
Q3 2022

May 10, 2024
BUY
$44.76 - $69.66 $108,677 - $169,134
2,428 Added 5.14%
49,665 $3.39 Million
Q3 2022

Jun 14, 2023
BUY
$44.76 - $69.66 $26,408 - $41,099
590 Added 1.2%
49,665 $3.39 Million
Q3 2022

Mar 22, 2023
BUY
$44.76 - $69.66 $108,677 - $169,134
2,428 Added 5.14%
49,665 $3.39 Million
Q3 2022

Nov 14, 2022
BUY
$44.76 - $69.66 $108,677 - $169,134
2,428 Added 5.14%
49,665 $3.39 Million
Q2 2022

May 10, 2024
BUY
$35.07 - $59.21 $208,456 - $351,944
5,944 Added 14.39%
47,237 $2.14 Million
Q2 2022

Jun 20, 2023
SELL
$35.07 - $59.21 $64,458 - $108,827
-1,838 Reduced 3.75%
47,237 $2.14 Million
Q2 2022

Mar 22, 2023
BUY
$35.07 - $59.21 $208,456 - $351,944
5,944 Added 14.39%
47,237 $2.14 Million
Q2 2022

Aug 11, 2022
BUY
$35.07 - $59.21 $208,456 - $351,944
5,944 Added 14.39%
47,237 $2.14 Million
Q1 2022

May 10, 2024
BUY
$35.46 - $54.12 $1.46 Million - $2.23 Million
41,293 New
41,293 $2.1 Million
Q1 2022

Jun 20, 2023
SELL
$35.46 - $54.12 $275,949 - $421,161
-7,782 Reduced 15.86%
41,293 $2.1 Million
Q1 2022

Mar 22, 2023
BUY
$35.46 - $54.12 $587,465 - $896,606
16,567 Added 67.0%
41,293 $2.1 Million
Q1 2022

May 12, 2022
BUY
$35.46 - $54.12 $587,465 - $896,606
16,567 Added 67.0%
41,293 $2.1 Million
Q4 2021

May 17, 2024
BUY
$30.74 - $49.16 $16,199 - $25,907
527 Added 2.18%
24,726 $1.17 Million
Q4 2021

Jun 21, 2023
SELL
$30.74 - $49.16 $748,488 - $1.2 Million
-24,349 Reduced 49.62%
24,726 $1.17 Million
Q4 2021

Mar 22, 2023
BUY
$30.74 - $49.16 $16,199 - $25,907
527 Added 2.18%
24,726 $1.17 Million
Q4 2021

Feb 15, 2022
BUY
$30.74 - $49.16 $16,199 - $25,907
527 Added 2.18%
24,726 $1.17 Million
Q3 2021

Jun 21, 2023
SELL
$31.4 - $69.84 $781,106 - $1.74 Million
-24,876 Reduced 50.69%
24,199 $797,000
Q2 2021

Jun 21, 2023
SELL
$40.9 - $64.9 $1.02 Million - $1.61 Million
-24,876 Reduced 50.69%
24,199 $1.53 Million
Q1 2021

May 17, 2024
BUY
$40.8 - $57.39 $736,562 - $1.04 Million
18,053 Added 293.74%
24,199 $1.04 Million
Q1 2021

Jun 26, 2023
SELL
$40.8 - $57.39 $1.01 Million - $1.43 Million
-24,876 Reduced 50.69%
24,199 $1.04 Billion
Q4 2020

May 24, 2024
SELL
$30.79 - $57.2 $78,576 - $145,974
-2,552 Reduced 9.54%
24,199 $1.38 Million
Q4 2020

Jun 22, 2023
SELL
$30.79 - $57.2 $765,932 - $1.42 Million
-24,876 Reduced 50.69%
24,199 $1.38 Million
Q4 2020

Mar 22, 2023
SELL
$30.79 - $57.2 $78,576 - $145,974
-2,552 Reduced 9.54%
24,199 $1.38 Million
Q4 2020

Feb 16, 2021
SELL
$30.79 - $57.2 $78,576 - $145,974
-2,552 Reduced 9.54%
24,199 $1.38 Million
Q3 2020

Jun 26, 2023
SELL
$25.89 - $33.65 $577,968 - $751,202
-22,324 Reduced 45.49%
26,751 $807,000
Q2 2020

May 24, 2024
BUY
$24.8 - $38.49 $511,004 - $793,086
20,605 Added 335.26%
26,751 $874 Million
Q2 2020

Jun 26, 2023
SELL
$24.8 - $38.49 $553,635 - $859,250
-22,324 Reduced 45.49%
26,751 $873,000
Q2 2020

Mar 22, 2023
BUY
$24.8 - $38.49 $34,397 - $53,385
1,387 Added 5.47%
26,751 $873,000
Q2 2020

Aug 14, 2020
BUY
$24.8 - $38.49 $34,397 - $53,385
1,387 Added 5.47%
26,751 $874,000
Q1 2020

Jul 12, 2023
SELL
$17.91 - $44.33 $424,664 - $1.05 Million
-23,711 Reduced 48.32%
25,364 $679,000
Q1 2020

Mar 22, 2023
BUY
$17.91 - $44.33 $54,965 - $136,048
3,069 Added 13.77%
25,364 $679,000
Q1 2020

May 15, 2020
BUY
$17.91 - $44.33 $54,965 - $136,048
3,069 Added 13.77%
25,364 $680,000
Q4 2019

Jul 12, 2023
SELL
$22.1 - $30.8 $591,838 - $824,824
-26,780 Reduced 54.57%
22,295 $682,000
Q3 2019

Jul 12, 2023
SELL
$24.09 - $32.18 $645,130 - $861,780
-26,780 Reduced 54.57%
22,295 $537,000
Q3 2019

Mar 22, 2023
BUY
$24.09 - $32.18 $120,377 - $160,803
4,997 Added 28.89%
22,295 $537,000
Q3 2019

Nov 14, 2019
BUY
$24.09 - $32.18 $120,377 - $160,803
4,997 Added 28.89%
22,295 $537,000
Q2 2019

Jul 12, 2023
SELL
$18.0 - $25.34 $482,040 - $678,605
-26,780 Reduced 54.57%
22,295 $564,000
Q1 2019

Jul 13, 2023
SELL
$12.81 - $19.82 $407,063 - $629,820
-31,777 Reduced 64.75%
17,298 $337,000
Q4 2018

Jul 13, 2023
SELL
$11.47 - $18.71 $364,482 - $594,547
-31,777 Reduced 64.75%
17,298 $228,000
Q4 2018

Mar 22, 2023
SELL
$11.47 - $18.71 $109,435 - $178,512
-9,541 Reduced 35.55%
17,298 $228,000
Q4 2018

Feb 14, 2019
SELL
$11.47 - $18.71 $109,435 - $178,512
-9,541 Reduced 35.55%
17,298 $228,000
Q3 2018

Jul 13, 2023
SELL
$16.57 - $21.03 $526,544 - $668,270
-31,777 Reduced 64.75%
17,298 $307,000
Q3 2018

Mar 22, 2023
SELL
$16.57 - $21.03 $378,226 - $480,030
-22,826 Reduced 45.96%
26,839 $477,000
Q3 2018

Nov 14, 2018
BUY
$16.57 - $21.03 $444,722 - $564,424
26,839 New
26,839 $477,000
Q2 2018

Aug 15, 2018
SELL
$19.63 - $30.0 $112,205 - $171,480
-5,716 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$14.01 - $26.02 $80,081 - $148,730
5,716 New
5,716 $126,000

Others Institutions Holding APLS

# of Institutions
308
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.64B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email